# UBBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ubbio

- Industry: Biotechnology
- Headquarters: Ningbo, China
- Website: www.ubbiotech.com.cn
- Latest round: Series A (Nov 22, 2022)
- Investors on record: 1

## About

Based in Zhejiang, China, and founded in 2017, UBBio operates as a medical device supplier specialized in the R&D, production, and sales of IVD (In Vitro Diagnostic) products, with ISO Class 5, ISO Class 4 purification GMP Workshop, specialist research and processing equipment and a working IDMF (Information Data Management Facility). Besides, it has an R&D branch office located in Hangzhou. It had partnerships with Zhejiang Hospital, Shaoxing Central Hospital, Hangzhou Cancer Hospital, etc.

The company is committed to the development of senior diagnosis products of cell and molecular genetics and supports the solutions of cell and molecular genetics for public health management. The products can be categorized into science and technology services, reagents, and clinical and research instruments?. It also provides the flow cytometry application in the subcellular qualitative/quantitative for clinical-detection solutions.

## Funding rounds

- Series A, Nov 22, 2022 — YuanBio Venture

## Investors

- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A